ARR3 and Huntington disease: We found that Arr3 mRNA levels were unchanged at the pre-symptomatic stage of R6/1, R6/2, and HdhQ150 mouse models, while there was a significant reduction, on average by 60%, of Arr3 transcripts at the symptomatic and end-stages, in all three HD mouse models (Figure 4A).